Skip to content

Active Knee Prosthesis Study

Active Knee Prosthesis Study

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06700668
Enrollment
7
Registered
2024-11-22
Start date
2008-04-17
Completion date
2026-07-17
Last updated
2025-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Transfemoral Amputation

Brief summary

The purpose of the study is to investigate the clinical and functional outcomes of a powered knee prosthesis for people with a transfemoral amputation in the domain of gait, free space control, and embodiment

Interventions

DEVICEMIT Powered Knee

MIT powered knee prosthesis developed by the MIT Biomechatronics Group.

Sponsors

U.S. Army Medical Research and Development Command
CollaboratorFED
Massachusetts Institute of Technology
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
22 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Male or Female age 22-65. * The patient must have a unilateral transfemoral amputation . * The patient must have the ability to ambulate at variable cadence (an expected lower extremity prosthesis functional level of K3 or above). * The patient must have adequate socket to support the device.

Exclusion criteria

* Women who are pregnant. * Severe co morbidity, atypical skeletal anatomy, or poor general physical/mental health that, in the opinion of the Investigator, will not allow the subject to be a good study candidate (i.e. other disease processes, mental capacity, substance abuse, shortened life expectancy, vulnerable patient population, BMI \>40, etc.).

Design outcomes

Primary

MeasureTime frameDescription
Metabolic costAn average of 2 sessions in the span of 1 weekEffort of participants' walking measured via metabolic cost, which is measured using an mask that measures the Oxygen and Carbon dioxide levels.

Secondary

MeasureTime frameDescription
Ground reaction forceAn average of 2 sessions in the span of 1 weekGround reaction forces will be measured via force plates on the ground.
Gait kinematicsAn average of 2 sessions in the span of 1 weekMotion capture data will be collected using a validated system (e.g., Vicon, or similar motion capture software). Reflective markers will be placed on anatomical landmarks following a standard gait model. Kinematic measures, including joint angles (hip, knee, and ankle), step length, stride length, cadence, and walking speed, will be derived.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026